Filter
111
Filtered Results: 111
Text search:
M.
Vitoriaa
Featured
Recommendations
14
New Publications
23
Language
Document type
No document type
72
Guidelines
21
Studies & Reports
15
Fact sheets
2
Manuals
1
Countries / Regions
Eastern Europe
5
Russia
4
Ukraine
2
Armenia
2
Global
2
Latin America and the Carribbean
2
Western and Central Europe
2
Brazil
2
North Macedonia
1
Thailand
1
Estonia
1
Mozambique
1
Africa
1
Eastern Europe and Central Asia
1
North America
1
Belgium
1
Belarus
1
South Africa
1
Georgia
1
Ethiopia
1
Authors & Publishers
Publication Years
Category
HIV & STI
16
TB
3
Communicable Diseases
2
Hepatitis
2
Guidelines
2
Maternal Health
2
Paediatrics
1
Buruli Ulcer
1
Humanitarian Aid
1
COVID-19
1
Public Health
1
Sexual Violence
1
Pediatrics
1
Countries
1
NCD
1
Cardiovascular Diseases
1
Child protection
1
Yellow Fever
1
Policies & Guidelines HIV & TB
1
Drugs & Medical Equipment
1
Studies & Reports
1
Humanitarian Crisis
1
Other
1
WASH
1
Gynaecology & Obstetrics
1
Neurology & Psychology
1
Water
1
Reproductive Health
1
Pharmacy & Technologies
1
Toolboxes
Antiretroviral Treatment ART
12
HIV in Key Populations
12
TB/HIV Coinfection
11
Clinical Aspects, Treatment & Prevention
10
Transgender People
8
Treatment Guidelines HIV
6
ART Drug Resistance
5
General
5
Treatment & Prevention
4
Children & Adolescents
4
Drug resistance
4
Postexposure Prophylaxis (PEP), Pre-Exposure Prophylaxis (PrEP)
4
HIV testing & services
3
Clinical Aspects
3
Opportunistic Infections
3
Access to treatment and laboratory
3
Co-Morbidities (except TB)
3
Reports & Studies
3
Policies & Strategies
2
General Reports
2
TB & Drug Abuse
2
Prevention & Control
2
Eastern Europe
2
Men who have sex with men (MSM)
2
TB/HIV
2
Drug resistant TB
2
Neurological Disorders
2
Substance Use Disorders & Addiction
2
Disease Prevention & Control
2
TB/HIV Global
2
Latin America & the Carribean
2
Clinical Guidelines
2
HIV service delivery
2
Drugs
1
Public Health
1
Childhood TB
1
Background PTSD in children
1
Vaccines & Immunization
1
Yellow Fever
1
Violence & Protection
1
Adults
1
HIV surveillance
1
Prevention Guidelines
1
Schizophrenia
1
HIV testing & disclosure
1
Hepatitis
1
HIV
1
General Studies & Reports
1
Others
1
Prophylaxis
1
Vaccination
1
Attention deficit hyperactivity disorder (ADHD)
1
Mental Health Guidelines
1
Reports
1
Russia
1
Sex Worker
1
Manuals
1
Key Resources
1
Laboratory
1
Studies
1
Infection Prevention & Hygiene
1
COVID-19
1
Country Specific
1
For Migrants & Refugees
1
Country specific documents
1
Prison & Detention
1
Child Protection
1
Paediatrics
1
Children & Mental Health
1
Oxygen Therapy
1
Gambling
1
Community Health Workers CHW
1
HIV &TB
1
Epilepsy
1
Mental Disorders
1
Prevention & Measures
1
Clinical Aspects & Diagnostics
1
Studies & Reports
1
Studies & Reports
1
Taeniasis/Cysticercosis
1
Awareness
1
Armenia
1
General
1
Detection & Diagnosis
1
Policies and guidelines
1
Community Worker
1
Bipolar Affective Disorders
1
Prophylactic Treatment
1
Nutrition
1
Research & Access
1
HIV and coinfection
1
WASH
1
Epidemiology
1
Depression
1
Eastern and Southern Africa
1
Cyclones Idai & Kenneth
1
Ces lignes directrices prônent une approche centrée sur la personne des informations stratégiques sur le VIH, ce qui implique de cesser de collecter des données agrégées dans les services (par exemple, le nombre de tests de dépistage du VIH administrés) pour s’intéresser au patient qui re...
Guías para programas nacionales y otros interesados directos
Recommendations for a public health approach
HIV/AIDS Programme
Technical Update
Areas of Africa endemic for Buruli ulcer (BU), caused by Mycobacterium ulcerans, also have a high prevalence of human immunodeficiency virus (HIV), with adult prevalence rates between 1% and 5% (Maps). However, there is limited information on the prevalence of BU–HIV coinfection....
The update of the ESTC was conducted as a joint endeavour with ERS, consulting experts from international societies and organisations, national TB programmes, civil society and affected communities. The second edition of the ESTC includes 21 standards in the areas of diagnosis, treatment, HIV and co...
The objectives of these guidelines are to provide recommendations outlining a public health approach to managing people presenting with advanced HIV disease, and to provide guidance on the timing of initiation of antiretroviral therapy (ART) for all people living with HIV.
WHO recommends that a...
WHO recommends that a...
The objectives of these WHO guidelines are to provide updated evidence- based recommendations for the treatment of persons with hepatitis C infection using, where possible, all DAA-only combinations. The guidelines also provide recommendations on the preferred regimens based on a patient’s HCV gen...
Módulo 1
Clínico
Julho de 2017
Módulo 1: Clínico. Este módulo é destinado a profissionais de saúde como médicos, enfermeiros e auxiliares e traz um resumo sobre como prover a PrEP de forma segura e efetiva, abordando vários aspectos: triagem de pessoas com risco substancial de contr...
These guidelines provide new and updated recommendations on the use of point-of-care testing in children under 18 months of age and point-of-care tests to monitor treatment in people living with HIV; the treatment monitoring algorithm; and timing of antiretroviral therapy (ART) among people living w...
This document synthesizes key elements of the World Health Organization (WHO) normative guidance on health policy and system support for community health worker (CHW) programmes and their application for HIV programmes. Building on relevant elements of HIV guidelines, tools and evidence identified b...
WHO’s sentinel surveys of acquired HIV resistance to dolutegravir among people receiving dolutegravir-containing antiretroviral therapy is intended for easy and frequent implementation. Results from sentinel surveys provide insight into the prevalence and year-over-year trends of dolutegravir resi...
Avec l’essor des traitements antirétroviraux (TAR) à base de dolutégravir (DTG) pour soigner les personnes vivant avec
le VIH dans le monde, il est important d’estimer la vitesse à laquelle la résistance acquise au DTG apparaît dans les
populations sous TAR. Bien que la résistance au DT...
A medida que el tratamiento antirretrovírico con dolutegravir se extiende a más personas que viven con el VIH en el
mundo, adquiere más importancia estimar la frecuencia con que surge la farmacorresistencia adquirida a este
antirretrovírico en las poblaciones tratadas con esquemas que lo conti...
